Intervention

recombinant fowlpox-CEA(6D)/TRICOM vaccine

ClinicalTrials.gov intervention label

Clinical trials6
Recruiting0
Common conditions25
Lead sponsors shown2

Clinical trials

6 shown
Denileukin Diftitox Followed by Vaccine Therapy in Treating Patients With Metastatic CancerNCT00128622 · 2005-09-01
COMPLETED
Vaccine Therapy, Chemotherapy, and Radiation Therapy in Treating Patients With Stage III Non-Small Cell Lung Cancer That Cannot Be Removed With SurgeryNCT00091039 · 2004-08-01
COMPLETED
Vaccine Therapy and Sargramostim With or Without Docetaxel in Treating Patients With Metastatic Lung Cancer or Metastatic Colorectal CancerNCT00088933 · 2004-06-01
TERMINATED
Vaccine and Chemotherapy for Previously Untreated Metastatic Breast CancerNCT00048893 · 2002-11-01
TERMINATED
Vaccine Therapy Plus Sargramostim and Chemotherapy in Treating Women With Stage II or Stage III Breast CancerNCT00052351 · 2002-09-01
COMPLETED
Vaccine Therapy With or Without Sargramostim in Treating Patients With Advanced or Metastatic CancerNCT00028496 · 2001-11-01
COMPLETED

Common conditions

Breast Cancer2Lung Cancer2Recurrent Colon Cancer2Recurrent Rectal Cancer2Stage IV Colon Cancer2Stage IV Rectal Cancer2Adenocarcinoma of the Colon1Adenocarcinoma of the Gallbladder1Adenocarcinoma of the Pancreas1Adenocarcinoma of the Rectum1Adult Primary Hepatocellular Carcinoma1Advanced Adult Primary Liver Cancer1Breast Neoplasms1Cholangiocarcinoma of the Gallbladder1Colorectal Cancer1Diffuse Adenocarcinoma of the Stomach1Extensive Stage Small Cell Lung Cancer1Intestinal Adenocarcinoma of the Stomach1Male Breast Cancer1Metastases, Neoplasm1Mixed Adenocarcinoma of the Stomach1Ovarian Endometrioid Adenocarcinoma1Paget Disease of the Breast With Intraductal Carcinoma1Paget Disease of the Breast With Invasive Ductal Carcinoma1Pancreatic Cancer1

Trial status mix

COMPLETED4
TERMINATED2

Phase mix

PHASE14
PHASE22
NA1

How to interpret this record

CureCurrent links normalized diseases, medicines, registry study labels, sponsors and research sites. A link is not the same as a finding of clinical effectiveness. Our research guides explain how to compare studies, decode RxNorm identities, and avoid over-interpreting site and trial counts. See the published database coverage for mapping completeness.

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.